PDGFRB and chordoma: This study was performed because: 1) experience from a clinical trial demonstrated variable clinical response of chordomas to PDGFR inhibition despite all tumors showing activation of PDGFR; and 2) our in vitro laboratory observation of intertumoral variation in growth rate and response to PDGR inhibition of chordoma cells.